Company news

QuidelOrtho Corporation news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

QuidelOrtho Reports First Quarter 2025 Financial Results

May 6, 2025

QuidelOrtho to Report First Quarter 2025 Financial Results

April 22, 2025

QuidelOrtho® Introduces Results Manager™ System

March 9, 2025

QuidelOrtho to Participate in the 46th Annual Raymond James Institutional Investor Conference

February 23, 2025

QuidelOrtho Reports Fourth Quarter and Full-Year 2024 Financial Results

February 11, 2025

QuidelOrtho Announces Preliminary Unaudited Revenue for Fourth Quarter 2024

January 12, 2025

QuidelOrtho to Present at the 43rd Annual J.P. Morgan Healthcare Conference

December 30, 2024

QuidelOrtho Announces Appointment of Two Independent Directors to its Board

December 9, 2024

QuidelOrtho Corporation Announces Secondary Offering of Common Stock by the Carlyle Group

November 18, 2024

QuidelOrtho Corporation Announces Pricing of Secondary Offering of Common Stock by the Carlyle Group

November 18, 2024

QuidelOrtho Reports Third Quarter 2024 Financial Results

November 6, 2024

QuidelOrtho to Participate in Three Upcoming Investor Conferences

October 27, 2024

QuidelOrtho to Report Third Quarter 2024 Financial Results

October 16, 2024

QuidelOrtho Announces New R&D Executive Leader

October 8, 2024

QuidelOrtho Appoints Lee Bowman as Chief Human Resources Officer

September 9, 2024

VITROS® Syphilis Assay Now Available on VITROS 3600 Immunodiagnostic System, VITROS 5600 and VITROS XT 7600 Integrated Systems in the U.S.

August 28, 2024

QuidelOrtho Reports Second Quarter 2024 Financial Results

July 30, 2024

QuidelOrtho to Report Second Quarter 2024 Financial Results

July 16, 2024

QuidelOrtho to Participate in 44th Annual William Blair Growth Stock Conference

May 22, 2024

QuidelOrtho Opens New Distribution Center in Pedricktown, NJ

May 14, 2024

QuidelOrtho Reports First Quarter 2024 Financial Results

May 7, 2024

QuidelOrtho Appoints Brian J. Blaser as President and Chief Executive Officer

May 1, 2024

QuidelOrtho To Report First Quarter 2024 Financial Results

April 16, 2024

QuidelOrtho Adds Fentanyl Test to Its Vitros® Systems as a MicroTip® Partnership Assay

April 9, 2024

QuidelOrtho Receives FDA 510(k) Clearance for Its QuickVue® COVID-19 Test

April 1, 2024

QuidelOrtho to Participate in 45th Annual Raymond James Institutional Investor Conference

February 25, 2024

QuidelOrtho Announces Changes in Executive Leadership

February 20, 2024

QuidelOrtho Reports Fourth Quarter and Full-Year 2023 Financial Results

February 12, 2024

QuidelOrtho to Report Fourth Quarter and Full-year 2023 Financial Results

January 22, 2024

QuidelOrtho to Present at 42nd Annual J.P. Morgan Healthcare Conference

December 21, 2023

QuidelOrtho Receives 510(K) Clearance for Savanna® Multiplex Molecular Platform and Savanna® HSV 1+2/VZV PCR Assay

December 19, 2023

QuidelOrtho to Participate in the Evercore ISI Conference

November 15, 2023

QuidelOrtho Reports Third Quarter 2023 Financial Results

October 31, 2023

QuidelOrtho Reports Preliminary Revenue Results for the Third Quarter 2023

October 11, 2023

QuidelOrtho Receives CLIA Waiver for Sofia® 2 SARS Antigen+ FIA

September 20, 2023

QuidelOrtho to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference

August 27, 2023

QuidelOrtho Reports Second Quarter 2023 Financial Results

August 7, 2023

QuidelOrtho Ranks No. 1 in Customer Satisfaction for Six Years in a Row

July 24, 2023

QuidelOrtho Partners With BYG4lab® to Strengthen Informatics Offerings

July 23, 2023

QuidelOrtho to Report Second Quarter 2023 Financial Results

July 17, 2023

QuidelOrtho to Participate in William Blair 43rd Annual Growth Stock Conference

May 22, 2023

QuidelOrtho Reports First Quarter 2023 Financial Results

May 2, 2023

QuidelOrtho Reports Preliminary Revenue Results for the First Quarter 2023

April 12, 2023

QuidelOrtho Announces the Formation of the International QuidelOrtho Women’s Leadership Network (QWLN)

March 27, 2023

QuidelOrtho Receives De Novo FDA Authorization for Sofia® 2 SARS Antigen+ FIA

March 7, 2023

QuidelOrtho to Participate in the Raymond James 44th Annual Institutional Investor Conference

March 1, 2023

ImageMover and QuidelOrtho Partner to Simplify Test-to-Treat Process for Pharmacies

February 26, 2023

QuidelOrtho Reports Fourth Quarter and Full Year 2022 Financial Results

February 14, 2023

QuidelOrtho Reports Preliminary Revenue Results for Fourth Quarter and Full Year 2022

January 5, 2023

QuidelOrtho to Present at the J.P. Morgan Healthcare Conference

December 27, 2022

← Newer news releases · Older news releases →

Calls

The 5 newest of 25 calls. Every call is listed under its year.

Decks

The 5 newest of 45 decks. Every deck is listed under its year.